Xenon Pharmaceuticals Inc is a progressive clinical-stage biopharmaceutical corporation focused on developing innovative therapies to enhance the lives of patients with neurological disorders. The company works in designing paths toward vitally needed drugs, employing its innovative Extreme Genetics discovery platform for ultimately solving the mysteries of disease.
Operating within the biopharmaceutical industry, Xenon offers an array of incredibly specialised services, including the research, development, and marketing of pharmaceutical products.
Keep up to date on the latest share price changes by adding XENE stock to your eToro watchlist.